ARK™ Pregabalin II Assay 5059-0001-00

GUDID 00812101030448

The ARK™ Pregabalin II Assay is an immunoassay intended for the qualitative and/or semiquantitative determination of pregabalin in human urine at a cutoff concentration of 500 ng/mL.

ARK DIAGNOSTICS INC

Multiple anticonvulsant therapeutic drug monitoring IVD, reagent
Primary Device ID00812101030448
NIH Device Record Keyf20bcd44-550a-4917-9ae9-4923f72c5c16
Commercial Distribution StatusIn Commercial Distribution
Brand NameARK™ Pregabalin II Assay
Version Model Number5059-0001-00
Catalog Number5059-0001-00
Company DUNS164880598
Company NameARK DIAGNOSTICS INC
Device Count1
DM Exemptfalse
Pre-market Exemptfalse
MRI Safety StatusLabeling does not contain MRI Safety Information
Human Cell/Tissue Productfalse
Device Kittrue
Device Combination Productfalse
Single Usetrue
Lot Batchtrue
Serial Numberfalse
Manufacturing Datefalse
Expiration Datetrue
Donation Id Numberfalse
Contains Natural Rubber Latexfalse
Labeled No Natural Rubber Latexfalse
RX Perscriptiontrue
OTC Over-The-Counterfalse

Customer Support Contacts

Phone5102706270
Emailcustomersupport@ark-tdm.com

Operating and Storage Conditions

Storage Environment TemperatureBetween 2 Degrees Celsius and 8 Degrees Celsius

Device Identifiers

Device Issuing AgencyDevice ID
GS100812101030448 [Primary]

FDA Product Code

NWMImmunoassay, Anti-Seizure Drug

Sterilization

Steralize Prior To Usefalse
Device Is Sterilefalse

Device Entry Metadata

Public Version StatusNew
Device Record StatusPublished
Public Version Number1
Public Version Date2019-07-11
Device Publish Date2019-07-03

On-Brand Devices [ARK™ Pregabalin II Assay]

00812101030448The ARK™ Pregabalin II Assay is an immunoassay intended for the qualitative and/or semiquantit
00812101031261The ARK™ Pregabalin II Assay is an immunoassay intended for the qualitative and /or semi-quant

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.